Conventional Tl-201 and hexakis 2-methoxy-2-isobutyl isonitrile studies are
less accurate as compared to FDG PET in the prediction of functional recov
ery after revascularization in patients with injured but viable myocardium.
The introduction of a dual-head variable-angle-geometry scintillation came
ra equipped with thicker crystals (5/8 in.) and high-resolution, ultrahigh-
energy collimators capable of 511 keV imaging has permitted FDG SPECT to pr
ovide information equivalent to that of PET for the detection of injured bu
t viable myocardium in patients with chronic ischemic heart disease. The de
velopment of standardized glucose-loading protocols, including glucose-insu
lin-potassium infusion and the potential use of nicotinic acid derivatives,
has simplified the method of obtaining consistently good-to-excellent qual
ity FDG SPECT cardiac studies. FDG SPECT may become the modality of choice
for evaluating injured but viable myocardium because of enhanced availabili
ty of FDG, logistics, patient convenience, accuracy and cost-effectiveness
compared to PET.